PBE
Invesco Biotechnology & Genome ETF
NAV as of
4 Week: 57.04 - 61.97
52 Week: 57.04 - 68.03
Latest Closing Price
57.04
Premium / Discount
0.1
Expense Ratio
0.58%
Investment Objective
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -10.17 | 1.16 | -8.75 |
| 1 Day | -0.81 | 0.00 | 0.00 |
| 1 Week | -0.79 | 1.74 | -0.45 |
| 1 Month | -7.50 | 3.87 | -1.94 |
| 3 Months | -5.35 | 7.31 | -0.73 |
| 6 Months | -8.32 | 11.88 | -0.70 |
| 1 Year | -3.21 | 20.20 | -0.16 |
| 2 Years | -23.50 | 35.72 | -0.66 |
| 3 Years | 0.31 | 43.99 | 0.01 |
| 5 Years | -4.06 | 62.06 | -0.07 |
| 10 Years | 61.81 | 85.24 | 0.73 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 61.6798 | 36.3965 | 2.0088 | -23.0230 | 22.4252 | 0.2367 | 18.2491 | 25.4988 | 1.5543 | -10.7695 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 11.0000 | 1.0000 | 96.0000 | 93.0000 | 52.0000 | 52.0000 | 89.0000 | 41.0000 | 72.0000 | 42.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 15/12/2016 | 29/12/2016 | 0.1208 |
| 18/09/2014 | 30/10/2014 | 0.0431 |
| 19/06/2014 | 29/06/2014 | 0.2340 |
| 17/12/2009 | 30/12/2009 | 0.0755 |
Portfolio Data
Total Number of Holdings: 32
Number of Bond Holdings: 0
Number of Equity Holdings: 30
Total Market Value: 226,454,588
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Pacific Biosciences of California Inc | 5.6381 | 962,497 | 0 | 13,070,709 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 0.00 |
| Large | 21.41 |
| Medium | 31.96 |
| Small | 22.86 |
| Micro | 23.66 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
18.5300
Price/Book*
2.6706
Price/Sales*
4.4477
Price/Cash Flow*
14.1514
Dividend Yield*
0.4059
Growth Measures
Long-Term Earnings
9.7502
Historical Earnings
-0.2809
Sales Growth
9.6793
Cash-Flow Growth
-2.2410
Book-Value Growth
12.0868
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
